EMEA-001418-PIP02-15-M03
Key facts
| Invented name |
Vocabria
|
| Active substance |
Cabotegravir
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0102/2022
|
| PIP number |
EMEA-001418-PIP02-15-M03
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Prevention of human immunodeficiency virus (HIV-1) infection
|
| Route(s) of administration |
|
| Contact for public enquiries |
ViiV Healthcare UK Limited
E-mail: eu.paediatric-plans@gsk.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-001418-PIP02-15-M03
|
| Compliance opinion date |
20/05/2022
|
| Compliance outcome |
positive
|